StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
GAYATRIBI.BO$9.91-4.93%
Fair $9.91+0.0%

GAYATRIBI.BO

Gayatri BioOrganics Limited

Basic Materials / ChemicalsBSE

$9.91

-0.54 (-4.93%)

Fairly Valued+0.0%Fair Value $9.91Fund rank 30/100 · Data gapFallback financials|
SA 26/D
F-Score: 1/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 24%

FCF escenarios

weak_data · normalized FCF $-6.9M · quality 67.7/100

Data gap 30/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 33/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

26/100

D

Piotroski

1/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. ROE is 3.0%, below the 5% threshold
Thesis & Journal · GAYATRIBI.BOLocal privado en este navegador · Gayatri BioOrganics Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$781M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

3.0%

↑

Gross Margin

N/A

•

Debt/Equity

-1.02

↓
52-Week Range$10
$7$20

TradingView lightweight chart

GAYATRIBI.BO price, volumen y niveles de valoración

Último $10.42Periodo +48.9%
Fair value: $9.910

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

—

FCF CAGR

—

FCF margin

—

FCF / Net income

0.66x

Latest source

Provider fallback

Margin decomposition

Último año: revenue — · net income $-11.1M · FCF $-7.4M

2023-FY → 2026-FY

Gross margin

—— pts

Operating margin

—— pts

Net margin

—— pts

FCF margin

—— pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue————$16.7M
Net Income$-11.1M$-11.1M$-7.3M$-6.8M$-10.1M
EBITDA$-7.5M$-7.5M$-4.5M$-5.3M$-7.7M
EPS——-0.09-0.09-0.13
Gross Margin————4.8%
Operating Margin————-31.9%
Net Margin————-60.6%
Balance Sheet
Debt/Equity-1.02-1.02-1.03-1.03-1.03
Current Ratio0.490.49———
Cash Flow
Free Cash Flow$-7.4M$-7.4M$-5.5M$-6.9M$-5.6M
Returns
ROE3.0%3.0%2.0%1.9%2.9%
Growth & Yield
EPS Growth——0.0%30.8%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +39.1%

Total return

+39.1%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.09 → n/d

Residual

+39.1%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+39.1%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.